Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Pilot Study to Investigate Ocular Involvement and the Potential of Ocular Imaging for Non-invasive Screening for Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

NCT07690436 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT07690436
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07690436 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Pilot Study to Investigate Ocular Involvement and the Potential of Ocular Imaging for Non-invasive Screening for Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Recruiting
Start date
July 8, 2026
Completion date
June 18, 2027
Enrollment
500 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

transthyretin amyloid cardiomyopathy